Your browser doesn't support javascript.
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California.
Reitsma, Marissa B; Claypool, Anneke L; Vargo, Jason; Shete, Priya B; McCorvie, Ryan; Wheeler, William H; Rocha, David A; Myers, Jennifer F; Murray, Erin L; Bregman, Brooke; Dominguez, Deniz M; Nguyen, Alyssa D; Porse, Charsey; Fritz, Curtis L; Jain, Seema; Watt, James P; Salomon, Joshua A; Goldhaber-Fiebert, Jeremy D.
  • Reitsma MB; Marissa B. Reitsma is a PhD student in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University, in Stanford, California. She and Anneke Claypool contribut
  • Claypool AL; Anneke L. Claypool is a PhD candidate in the Department of Management Science and Engineering, Stanford University. She and Marissa Reitsma contributed equally to this article.
  • Vargo J; Jason Vargo is a lead research scientist in the Climate Change and Health Equity Program, Coronavirus Sciences Branch, and the Office of Health Equity, California Department of Public Health (CDPH), in Richmond, California.
  • Shete PB; Priya B. Shete is an assistant professor in the Division of Pulmonary and Critical Care Medicine and UCSF Center for Tuberculosis, University of California San Francisco, and the COVID-19 modeling and analytics lead in the Coronavirus Sciences Branch, CDPH.
  • McCorvie R; Ryan McCorvie is a statistician in the Coronavirus Sciences Branch, CDPH.
  • Wheeler WH; William H. Wheeler is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Rocha DA; David A. Rocha is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Myers JF; Jennifer F. Myers is a senior informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Murray EL; Erin L. Murray is an epidemiologist supervisor in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Bregman B; Brooke Bregman is a senior epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Dominguez DM; Deniz M. Dominguez is a surveillance program manager in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Nguyen AD; Alyssa D. Nguyen is a research scientist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Porse C; Charsey Porse is an epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Fritz CL; Curtis L. Fritz is the State Public Health Veterinarian in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.
  • Jain S; Seema Jain is the chief of the Disease Investigations Section, Infectious Diseases Branch, the Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.
  • Watt JP; James P. Watt is the chief of the Division of Communicable Disease Control, Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.
  • Salomon JA; Joshua A. Salomon is a professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.
  • Goldhaber-Fiebert JD; Jeremy D. Goldhaber-Fiebert (jeremygf@stanford.edu) is an associate professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.
Health Aff (Millwood) ; 40(6): 870-878, 2021 06.
Article in English | MEDLINE | ID: covidwho-1225818
ABSTRACT
With a population of forty million and substantial geographic variation in sociodemographics and health services, California is an important setting in which to study disparities. Its population (37.5 percent White, 39.1 percent Latino, 5.3 percent Black, and 14.4 percent Asian) experienced 59,258 COVID-19 deaths through April 14, 2021-the most of any state. We analyzed California's racial/ethnic disparities in COVID-19 exposure risks, testing rates, test positivity, and case rates through October 2020, combining data from 15.4 million SARS-CoV-2 tests with subcounty exposure risk estimates from the American Community Survey. We defined "high-exposure-risk" households as those with one or more essential workers and fewer rooms than inhabitants. Latino people in California are 8.1 times more likely to live in high-exposure-risk households than White people (23.6 percent versus 2.9 percent), are overrepresented in cumulative cases (3,784 versus 1,112 per 100,000 people), and are underrepresented in cumulative testing (35,635 versus 48,930 per 100,000 people). These risks and outcomes were worse for Latino people than for members of other racial/ethnic minority groups. Subcounty disparity analyses can inform targeting of interventions and resources, including community-based testing and vaccine access measures. Tracking COVID-19 disparities and developing equity-focused public health programming that mitigates the effects of systemic racism can help improve health outcomes among California's populations of color.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Health Aff (Millwood) Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Health Aff (Millwood) Year: 2021 Document Type: Article